EDUCATION AND TRAINING

Resident, University of Washington, Seattle, 1986–1987.

Junior Resident, Boise VA Medical Center, Idaho, 1985–1986.

Internship, University of Washington, Seattle, 1984–1985.

M.D., University of Washington School of Medicine, Seattle, 1984.

B.S, Biology/Chemistry University of Utah, Salt Lake City, 1980.

Edward A. Gill M.D., F.A.C.C.

Attending Physician, Harborview Medical Center
Attending Physician, University of Washington Medical Center

Director of Echocardiography, Harborview Medical Center

BOARD CERTIFICATION

Internal Medicine, Cardiovascular Disease, 1993 and 2004.

American Board of Clinical Lipidology, 2005.

American Board of Nuclear Cardiology, 2005.

National Board of Echocardiography, 1999.

Internal Medicine, 1987.

AREAS OF CLINICAL EXPERTISE

Valvular Heart Disease, especially Mitral Valve Prolapse and Mitral Stenosis

Congenital Heart Disease (Co-Director of Congenital Heart Disease Clinic at University of Colorado 1994-2000)

Preventive Cardiology: Lipidology, Carotid IMT

Three-Dimensional Cardiac Imaging: Cardiac MRI, Cardiac CT

CURRENT RESEARCH INTERESTS

Assessment of diastolic heart failure by cardiac MRI

Assessment of biventricular pacing using 2D and 3D echocardiography

Three-dimensional echocardiography (transthoracic) —Evaluation of valvular disease and left ventricular function

Diastolic heart failure

Assessment of source of embolus in stroke patients, particularly PFO

SPECIAL ACCOMPLISHMENTS

Awarded "Outstanding Cardiology Faculty," 1997–1998

RECENT PUBLICATIONS

LaFlamme MA, Chen KY, Naumova AV, Miskheli V, Fugate JA, Dupras SK, Reineck H, Xu C, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE. Cardiomyocytes derived from human embryonic stem cells in pro survival factors enhance function of infracted rat hearts. Nature Biotechnol 2007; 25:1015-1024.

Houck RC, Cooke JE, Gill EA. Live three-dimensional echo - an entire replacement for traditional two dimensional echo. American Journal of Roentgenology: 2006; October 187(4):1092-1106.

Pittenger B, Gill E. Carvedilol reduces QT dispersion in patients treated for congestive heart failure. Am J Cardiol 2004 Dec 1; 94(11):1459-62.

Lowes BD, Gill EA, Abraham WT, Larrain J-R, Robertson AD, Bristow MR, Gilbert EM. Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure. Am J Cardiol 1999; 83:1201-1205.

Shandas R, Kwon J, DeGroff CG, Trujillo NP, Gill EA, Valdes-Cruz L. Utility of three dimensional ultrasound Doppler flow reconstruction of the proximal jet to quantify regurgitant orifice area: In vitro Steady and Pulsatile flow Studies. J Am Soc Echocardiography, 1998; 11:313-21.